Study Summary
The aim of the study is to apply a novel clinical investigation protocol in patients with Phosphodiesterase 6A (PDE6A), PDE6B and Rhodopsin (RHO)-based retinitis pigmentosa. This novel, multimodal clinical examination protocol describes and correlates structural, functional and metabolic aspects during natural disease development. Test-retest variability of new measurements as well as correlations of the structural, functional, and metabolic changes will be defined to be able to define well-suited readouts for safety and efficacy of future treatment developments before they reach the clinical phase.
Want to learn more about this trial?
Request More InfoInterventions
No interventions listed.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Institute for Ophthalmic Research, University Tübingen | Tübingen | Baden-Wurttemberg | Germany |